Cargando…

Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections

OBJECTIVE: To examine the continuation of antibody prevalence and background factors in antibody-positive subjects after asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). METHODS: A study was carried out to investigate the SARS-CoV-2 antibody (IgG) prevalence....

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuba, Ikuro, Takuma, Tetsuo, Hatori, Nobuo, Takai, Masahiko, Watanabe, Yoshiyuki, Takada, Nobukazu, Kishi, Satoru, Matsuzawa, Yoko, Nishikawa, Tetsuo, Kunishima, Tomoyuki, Degawa, Hisakazu, Nishikawa, Masanori, Ono, Yoshiaki, Kanamori, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851192/ https://www.ncbi.nlm.nih.gov/pubmed/34744105 http://dx.doi.org/10.2169/internalmedicine.8019-21

Ejemplares similares

The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021
por: Matsuba, Ikuro, et al.
Publicado: (2022)

Survey of the current status of subclinical coronavirus disease 2019 (COVID-19)
por: Matsuba, Ikuro, et al.
Publicado: (2020)

Heterogeneity assessment of vaccine‐induced effects using point‐of‐care surrogate neutralization test for severe acute respiratory syndrome coronavirus 2
por: Watanabe, Yoshiyuki, et al.
Publicado: (2022)

Efficacy and Safety of Alogliptin in Elderly Patients With Type 2 Diabetes Mellitus
por: Takeda, Hiroshi, et al.
Publicado: (2019)

Efficacy and Safety of Alogliptin in Patients With Type 2 Diabetes: Analysis of the ATTAK-J Study
por: Takeda, Hiroshi, et al.
Publicado: (2016)

A survey of clinical physician's perceptions of stigma and advocacy in patients with type 2 diabetes in Kanagawa, Japan
por: Matsuzawa, Yoko, et al.
Publicado: (2022)

Is it Possible to Extirpate Cardiovascular Events in Primary Aldosteronism After Surgical Treatment
por: Nishikawa, Tetsuo, et al.
Publicado: (2010)

Vascular Aldosterone Production at the Pre-Diabetic Stage of Young Otsuka Long-Evans Tokushima Fatty (OLETF) Rats, Compared with Long-Evans Tokushima Otsuka (LETO) Rats
por: Matsuzawa, Yoko, et al.
Publicado: (2013)

A Study of Seasonal Variation in the Effect of Add-On Sitagliptin on Blood Glucose Control in Insulin-Treated Patients With Type 2 Diabetes
por: Takai, Masahiko, et al.
Publicado: (2020)

Association Between Aldosterone and Hypertension Among Patients With Overt and Subclinical Hypercortisolism
por: Inoue, Kosuke, et al.
Publicado: (2022)

Factors Associated With Reduced Efficacy of Sitagliptin Therapy: Analysis of 93 Patients With Type 2 Diabetes Treated for 1.5 Years or Longer
por: Kanamori, Akira, et al.
Publicado: (2013)

Alkalizer Administration Improves Renal Function in Hyperuricemia Associated with Obesity
por: Saito, Jun, et al.
Publicado: (2013)

Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration
por: Takashi, Yuichi, et al.
Publicado: (2018)

A Unique Case of Renovascular Hypertension due to Fibromuscular Dysplasia in an Extra-renal Artery
por: Sakuma, Ikki, et al.
Publicado: (2018)

Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetes
por: Takashi, Yuichi, et al.
Publicado: (2017)

MON-203 Aldosterone Biosynthesis Among Patients with Overt or Subclinical Cushing’s Syndrome
por: Inoue, Kosuke, et al.
Publicado: (2020)

Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study
por: Matsuba, Ikuro, et al.
Publicado: (2020)

Identification of the First Japanese Family Harboring a Novel Hemoglobin Variant “Perpignan”, Which Caused Low HbA(1c) Measurement During Diabetic Follow-Up
por: Nakamura, Mami, et al.
Publicado: (2011)

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Atherosclerosis, β-Cell Function, and Glycemic Control in Japanese Patients with Type 2 Diabetes Mellitus Who are Treatment Naïve or Poorly Responsive to Antidiabetes Agents: A Multicenter, Prospective Observational, Uncontrolled Study
por: Tsurutani, Yuya, et al.
Publicado: (2017)

Fasting Insulin Levels and Metabolic Risk Factors in Type 2 Diabetic Patients at the First Visit in Japan: A 10-year, nationwide, observational study (JDDM 28)
por: Matsuba, Ikuro, et al.
Publicado: (2012)

Present status of insulin therapy for type 2 diabetes treated by general practitioners and diabetes specialists in Japan: Third report of a cross‐sectional survey of 15,652 patients
por: Arai, Keiko, et al.
Publicado: (2012)

Nationwide Survey on Actual Interventions for Type 2 Diabetes by Japanese Practitioners (NSAID Study-1): Glycemic, Weight, and Blood Pressure Management
por: Arai, Keiko, et al.
Publicado: (2020)

Differences in Dental Care Referral for Diabetic Patients Between General Practitioners and Diabetes Specialists in Japan, Analyzed from NSAID-Study 3
por: Arai, Keiko, et al.
Publicado: (2021)

Impact of blood pressure on the outcomes of inpatients with Subarachnoid hemorrhage: A retrospective cross-sectional study
por: Saito, Naohito, et al.
Publicado: (2021)

Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
por: Iizuka, Takashi, et al.
Publicado: (2016)

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
por: Iizuka, Takashi, et al.
Publicado: (2016)

Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus
por: Kawata, Takehiro, et al.
Publicado: (2017)

Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study
por: Iemitsu, Kotaro, et al.
Publicado: (2017)

Clinical Translationality of KCNJ5 Mutation in Aldosterone Producing Adenoma
por: Kitamoto, Takumi, et al.
Publicado: (2022)

Factor Analysis of Changes in Hemoglobin A1c After 12 Months of Sitagliptin Therapy in Patients With Type 2 Diabetes
por: Yuasa, Shouhei, et al.
Publicado: (2016)

Imido-substituted triazines as dehydrative condensing reagents for the chemoselective formation of amides in the presence of free hydroxy groups
por: Kitamura, Masanori, et al.
Publicado: (2018)

Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa)
por: Hatori, Yutaka, et al.
Publicado: (2017)

HGPD: Human Gene and Protein Database, 2012 update
por: Maruyama, Yukio, et al.
Publicado: (2012)

Factors influencing the durability of the glucose‐lowering effect of sitagliptin combined with a sulfonylurea
por: Kubota, Akira, et al.
Publicado: (2014)

Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients
por: Kubota, Akira, et al.
Publicado: (2012)

Influence of stress induced by the first announced state of emergency due to coronavirus disease 2019 on outpatient blood pressure management in Japan
por: Kobayashi, Kazuo, et al.
Publicado: (2021)

Impact of the first announced state of emergency owing to coronavirus disease 2019 on stress and blood pressure levels among patients with type 2 diabetes mellitus in Japan
por: Ito, Shun, et al.
Publicado: (2022)

Identification and Functional Analyses of 11 769 Full-length Human cDNAs Focused on Alternative Splicing
por: Wakamatsu, Ai, et al.
Publicado: (2009)

Severe panuveitis with relapsing polychondritis
por: Masuda, Naonori, et al.
Publicado: (2018)

Mixed corticomedullary tumor of the adrenal gland
por: Kimura, Noriko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n1nbhco7bmjfmbeeoejkkoa28d